PROPERTY SEARCH
PROPERTY SEARCH
ARCHIVED - First cannabis-based medicine arrives in Spain
The pioneering drug will be used in treatment-resistant epilepsy patients in Spain
In a ground-breaking move in Spain, the first drug exclusively based on cannabidiol (CBD), a chemical substance extracted from cannabis, has been legally approved and is now available for sale. The medication, which will only be dispensed through hospital pharmacies, will be used in the treatment of epileptic seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) in patients from two years of age.
Epidyolex (the cannabis-based drug’s commercial name) is an oral solution that contains highly purified cannabidiol, or CBD. In September 2019, it received approval from the European Commission, making it the first cannabis-based prescription medicine derived from plants to receive this authorisation. The approval of cannabidiol oral solution was based on the results of four randomised controlled trials with data from more than 714 patients with both epileptic conditions. More than ten hospitals in Spain participated in the clinical development of the medication.
Antonio Gil-Nagel Rein, neurologist and director of the Epilepsy Program at the Ruber International Hospital in Madrid, has welcomed the news, adding that until now, the treatment options for both forms of epilepsy were very limited. The new drugs, he said, will contribute greatly to the quality of life of patients.
Lennox-Gastaut (LGS) and Dravet (SD) syndromes are two rare forms of epilepsy with high rates of mortality. Many patients with LGS or DS have multiple seizures each day, placing them at constant risk of falls and injuries. Despite current treatment with antiepileptic drugs, these two severe forms of epilepsy are highly resistant to traditional treatments.
Image: Archive
Address
C/Falucho 12, playasol 2, Bolnuevo 30877 Mazarron MurciaTel: +34 986 433 675 - 2pm to 8pm
Mobile: +34 609 801 594 - 8am to 8pm (whatsapp/call)
Mobile: +34 609 801 594 - 8am to 8pm (whatsapp/call)
The Iberoptima company uses modern scientific technology to provide the best CBD oil to clients across the Murcia region
Iberoptima is a Mazarrón-based CBD oil, supplements and vitamin company which uses state-of-the-art ‘Micelle’ enhanced technology to provide the best product to their customers.
This technology increases the absorption rates of CBD oil (cannabidiol) from between five and ten per cent to nearly 100%, up to 15 times more than other companies who don’t use Micelle enhanced products.
Micelle Enhanced CBD oil means that, instead of the products being dissolved in oil, which is not generally well-absorbed by the human body, the CBD compounds are coated 
with a layer of microscopic ball-shaped molecules, which are carried faster and more efficiently through the human body, allowing clients to get more for their money, as fewer drops are needed to get the desired effect.
Iberoptima products are sold in 10ml or 30ml bottles with built in droppers and cover a wide range of substances including fish oil, vitamin B12, vitamin C, ginger as well as CBD and CBN oils.
The CBD oils are bottled in Switzerland using organic materials and are designed to be dissolved in water and taken as required, keeping in mind that fewer drops than usual will be needed thanks to the Micelle enhancement.
Prices start at between 20 and 40 euros for a 10ml bottle and increase for larger bottles or trio packs. Iberoptima also offer special deals for larger quantity wholesales.
The company are based in Bolnuevo, Mazarrón (in the South West area of Murcia) and are open from 8am until 8pm.
Contact Spanish News Today: Editorial 966 260 896 /
Office 968 018 268
